2nd transnational joint call (JTC 2012)

Basic Information

Proposals must address the topic of translational research on primary & secondary prevention, covering at least one of the areas below: Primary cancer prevention a) Identification & validation of cancer etiology drivers, based on molecular epidemiology-derived evidences. b) Identification & validation of cancer preventive or predisposing factors, based on molecular epidemiology-derived evidences. c) Investigation, prompted by clinical trials results, of molecular mechanisms of action of potentially cancer preventive drugs & of their combination, with a particular focus on the identification of modalities for inducing synergistic effects. d) Clinical prevention trials of cancer-preventive agents. e) Development of strategies & tools for immune prevention of cancer. Secondary cancer prevention a) Validation of biomarkers & development of technologies & methodologies for early detection cancer screening. b) Research on integration of age & co-morbidity, in termsof underlying mechanisms

Network TRANSCAN
Website https://www.transcanfp7.eu
Aim of the joint call JTC 2012 aims at funding transnational innovative projects in cancer prevention, focused on the research of the mechanisms responsible for maintaining a healthy `STATUS` vs. those underlying cancer development, and clearly oriented towards a rapid translation of the existing and newly acquired knowledge into individual- or patient-tailored interventions at highest potential for cancer control.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 14/12/2012
Deadline Pre-Proposal 15/02/2013 Submitted proposal: 55
Deadline Full-Proposal 24/06/2013 Submitted proposal: 22
Evaluation End Date 31/10/2013 Successful proposal: n/a Proposals funded: 10
Is call co-funded? No
Call follow up funding
  • There are mechanisms in place to monitor technical progress
  • There are mechanisms in place to monitor
Call reasons
  • Access to expertise from different countries
  • Addressing specific scientific and technological issues
  • Sharing competences and associated work
  • Achieving critical mass
Research fields
  • Health
Type of research
  • Other: Translational research
Target groups
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • SME (Small and Medium Enterprises)
Participating networks n/a